| Symbol | ABVX |
|---|---|
| Name | ABIVAX S.A. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 7 BD HAUSSMANN, PARIS, None None |
| Telephone | 01 53 83 09 63 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001956827 |
| Description | None |
New Form SCHEDULE 13D/A - Abivax S.A. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001104659-26-080877 <b>Size:</b> 26 KB
Read moreAbivax annonce la réalisation de son offre au public de 920 millions de dollars
Read moreNew Form 424B5 - Abivax S.A. <b>Filed:</b> 2026-07-02 <b>AccNo:</b> 0001193125-26-294491 <b>Size:</b> 1 MB
Read moreAbivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
Read moreAbivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)
Read moreCorrection: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Read moreCorrection: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
Read moreAbivax announces trading resumption of its ordinary shares on Euronext Paris
Read moreAbivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Read more